{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:16:01Z","timestamp":1778040961882,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W1232"],"award-info":[{"award-number":["W1232"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35589"],"award-info":[{"award-number":["P35589"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["PRIN 2022 PNRR"],"award-info":[{"award-number":["PRIN 2022 PNRR"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009873","name":"Autonomous Region of Sardinia","doi-asserted-by":"publisher","award":["PNRR-MAD-2022-12375802"],"award-info":[{"award-number":["PNRR-MAD-2022-12375802"]}],"id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["T4-AN-10"],"award-info":[{"award-number":["T4-AN-10"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuropharm.2026.110969","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:18:55Z","timestamp":1776028735000},"page":"110969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimizing cognitive enhancement through dopamine transporter modulation"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-5791","authenticated-orcid":false,"given":"Marco","family":"Niello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Kalaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Cybulska-Klosowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kirchhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Spreitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7796-1147","authenticated-orcid":false,"given":"Markus","family":"Spreitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Wackerlig-Damle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-2369","authenticated-orcid":false,"given":"Michele","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5315-2898","authenticated-orcid":false,"given":"Claudia","family":"Sagheddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone B.","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Lubec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7315-9886","authenticated-orcid":false,"given":"Ahmed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-3370","authenticated-orcid":false,"given":"Nicolas","family":"Singewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pistis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Lubec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-7444","authenticated-orcid":false,"given":"Harald H.","family":"Sitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110969_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s002130000624","article-title":"Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans","volume":"154","author":"Abreu","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110969_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbr.2009.11.028","article-title":"Extending possible applications of an episodic-like memory task in rats","volume":"215","author":"Barbosa","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110969_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","article-title":"Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats","volume":"168","author":"Bauer","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107785","article-title":"Functional and biochemical consequences of disease variants in neurotransmitter transporters: a special emphasis on folding and trafficking deficits","volume":"222","author":"Bhat","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.110969_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/sleep\/27.6.1181","article-title":"What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications","volume":"27","author":"Boutrel","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2026.110969_bib6","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2011.13267","article-title":"Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets","volume":"141","author":"Bruggisser","year":"2011","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.neuropharm.2026.110969_bib7","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M112.343681","article-title":"The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters","volume":"287","author":"Bulling","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110969_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2004.02386.x","article-title":"Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine","volume":"89","author":"Chen","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110969_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrd.2015.18","article-title":"The drug-target residence time model: a 10-year retrospective","volume":"15","author":"Copeland","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110969_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110969_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tins.2004.03.011","article-title":"DAncing past the DAT at a DA synapse","volume":"27","author":"Cragg","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00432175","article-title":"Reinstatement of cocaine-reinforced responding in the rat","volume":"75","author":"de Wit","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110969_bib13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/mp300570z","article-title":"Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states","volume":"10","author":"Deo","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuropharm.2026.110969_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.105.091231","article-title":"Relationship between in Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy] ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine Analogs","volume":"315","author":"Desai","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110969_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.588160","article-title":"Noradrenergic source of dopamine assessed by microdialysis in the medial prefrontal cortex","volume":"11","author":"Devoto","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/biom12040506","article-title":"The novel analogue of modafinil CE-158 protects social memory against interference and triggers the release of dopamine in the nucleus accumbens of mice","volume":"12","author":"Ebner","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.110969_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1192\/bjp.bp.105.017335","article-title":"Modafinil and unconstrained motor activity in schizophrenia: double-blind crossover placebo-controlled trial","volume":"189","author":"Farrow","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110969_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-1047(86)90750-8","article-title":"Scopolamine effects on memory retention in mice: a model of dementia?","volume":"45","author":"Flood","year":"1986","journal-title":"Behav. Neural. Biol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109192","article-title":"The potent \u03b12-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride","volume":"217","author":"Frau","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110969_bib20","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2026.110969_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110969_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-008-1132-9","article-title":"Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study","volume":"202","author":"Goetghebeur","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110969_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bcpt.13838","article-title":"Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells","volume":"133","author":"Gopinath","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-44637-6","article-title":"Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors","volume":"15","author":"Gradisch","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110969_bib25","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1172\/JCI73778","article-title":"Missense dopamine transporter mutations associate with adult parkinsonism and ADHD","volume":"124","author":"Hansen","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.110969_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151496","article-title":"Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease","volume":"6","author":"Herborg","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuropharm.2026.110969_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41398-023-02493-4","article-title":"Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release","volume":"13","author":"Keighron","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110969_bib28","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-Coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110969_bib29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.110969_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0091-3057(96)00438-8","article-title":"Opponent process model and psychostimulant addiction","volume":"57","author":"Koob","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.110969_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/biom12070881","article-title":"A novel and selective dopamine transporter inhibitor, (S)-MK-26, promotes hippocampal synaptic plasticity and restores effort-related motivational dysfunctions","volume":"12","author":"Kouhnavardi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.110969_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110969_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/17425247.2016.1092519","article-title":"Brain-blood ratio: implications in brain drug delivery","volume":"13","author":"Kulkarni","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.neuropharm.2026.110969_bib34","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.1931-17.2018","article-title":"Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats","volume":"38","author":"Leo","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","article-title":"Dopamine reuptake and inhibitory mechanisms in human dopamine transporter","volume":"632","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110969_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110969_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11095-022-03246-6","article-title":"Unbound brain-to-plasma partition coefficient, Kp,uu,brain-a game changing parameter for CNS drug discovery and development","volume":"39","author":"Loryan","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2026.110969_bib38","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1038\/s41380-021-01214-x","article-title":"Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition","volume":"26","author":"Lubec","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110969_bib39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","article-title":"Designer drugs: mechanism of action and adverse effects","volume":"94","author":"Luethi","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1064-1297.15.2.123","article-title":"Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults","volume":"15","author":"Makris","year":"2007","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2026.110969_bib41","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","article-title":"Anomalous dopamine release associated with a human dopamine transporter coding variant","volume":"28","author":"Mazei-Robison","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.irn.2015.02.008","article-title":"Psychostimulants: basic and clinical pharmacology","volume":"120","author":"McCreary","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","article-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","volume":"229","author":"Mereu","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110969_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2026.110969_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.apha.2023.09.003","article-title":"Immunity on ice: the impact of methamphetamine on peripheral immunity","volume":"99","author":"Miller","year":"2024","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuropharm.2012.07.009","article-title":"Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers","volume":"64","author":"M\u00fcller","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110969_bib48","article-title":"Constraints associated with cognitive control and the stability-flexibility dilemma","volume":"40","author":"Musslick","year":"2018","journal-title":"Proceed. Annual Meet. Cogn. Sci. Soc."},{"key":"10.1016\/j.neuropharm.2026.110969_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.tics.2021.06.001","article-title":"Rationalizing constraints on the capacity for cognitive control","volume":"25","author":"Musslick","year":"2021","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib49","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.neurobiolaging.2008.07.007","article-title":"Age-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery","volume":"31","author":"Nagahara","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2026.110969_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-pharmtox-030220-124205","article-title":"New drugs, old targets: tweaking the dopamine system to treat psychostimulant use disorders","volume":"61","author":"Newman","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic - a focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.110969_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.654061","article-title":"Effects of hydroxylated mephedrone metabolites on monoamine transporter activity in vitro","volume":"12","author":"Niello","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114204120","article-title":"Persistent binding at dopamine transporters determines sustained psychostimulant effects","volume":"120","author":"Niello","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110969_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14055","article-title":"Pharmacological management of narcolepsy in children and adolescents","volume":"33","author":"Plazzi","year":"2024","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.neuropharm.2026.110969_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/bs.irn.2015.02.001","article-title":"Amphetamine-type stimulants: the early history of their medical and non-medical uses","volume":"120","author":"Rasmussen","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2026.110969_bib57","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_251","article-title":"Molecular mechanisms of amphetamines","author":"Reith","year":"2019"},{"key":"10.1016\/j.neuropharm.2026.110969_bib58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1126\/science.841307","article-title":"Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes","volume":"195","author":"Resnick","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110969_bib59","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110969_bib60","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2026.110969_bib61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002826-200401000-00011","article-title":"Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia","volume":"27","author":"Rosenthal","year":"2004","journal-title":"Clin. Neuropharmacol."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.110969_bib62","first-page":"1783","article-title":"Maternal immune activation and the endocannabinoid system: focus on two-hit models of schizophrenia","volume":"S0006\u20133223","author":"Santoni","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110969_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.191056","article-title":"Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates","volume":"346","author":"Schmitt","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110969_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cercor\/bhy264","article-title":"Dopamine signaling modulates the stability and integration of intrinsic brain networks","volume":"29","author":"Shafiei","year":"2019","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2026.110969_bib66","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","article-title":"Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter","volume":"71","author":"Sitte","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110969_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316956","article-title":"Pharmacokinetics of novel dopamine transporter inhibitor CE-123 and modafinil with a focus on central nervous system distribution","volume":"24","author":"Spreitzer","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110969_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.baga.2016.02.001","article-title":"Striatal dopamine neurotransmission: regulation of release and uptake","volume":"6","author":"Sulzer","year":"2016","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.neuropharm.2026.110969_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coph.2020.07.007","article-title":"Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder","volume":"56","author":"Tanda","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s42003-023-04545-3","article-title":"Time-varying SUVr reflects the dynamics of dopamine increases during methylphenidate challenges in humans","volume":"6","author":"Tomasi","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.euroneuro.2010.03.005","article-title":"The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization","volume":"20","author":"Vel\u00e1zquez-S\u00e1nchez","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110969_bib73","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110969_bib74","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2174\/138161206777698819","article-title":"Effects of modafinil on cognitive performance and alertness during sleep deprivation","volume":"12","author":"Wesensten","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2026.110969_bib75","article-title":"Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions","volume":"4 OCT","author":"Wisor","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110969_bib76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/pr.112.007054","article-title":"Psychostimulants and cognition: a continuum of behavioral and cognitive activation","volume":"66","author":"Wood","year":"2013","journal-title":"Pharmacol. Rev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:05:18Z","timestamp":1778040318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"alternative-id":["S0028390826001425"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110969","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing cognitive enhancement through dopamine transporter modulation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110969"}}